Introduction to Haemonetics Corporation

Haemonetics Corporation is a globally recognized medical technology company headquartered in Boston, Massachusetts, with a strong presence in over 50 countries. The company specializes in developing and manufacturing integrated solutions for blood management, plasma collection, and surgical blood conservation. As a key player in the healthcare industry, Haemonetics serves hospitals, blood banks, plasma fractionators, and clinical laboratories worldwide. The company’s market reputation is built on decades of innovation, regulatory compliance, and a commitment to improving patient outcomes. With annual revenues exceeding $1 billion and a workforce of over 3,500 employees, Haemonetics is a trusted partner in the healthcare ecosystem. Organizations rely on its advanced technologies to enhance safety, efficiency, and quality in blood component collection and transfusion processes. This comprehensive profile delves into the company’s history, culture, products, and career opportunities, highlighting why Haemonetics is a top choice for professionals in the healthcare and medical device sectors.

Company History and Business Evolution

Haemonetics was founded in 1971 by Dr. James H. (“Jim”) T. McAleer and a team of engineers who pioneered the first automated blood cell separator. The company quickly established itself as a leader in apheresis technology, enabling the safe collection of specific blood components such as platelets and plasma. Over the decades, Haemonetics expanded its product portfolio through strategic acquisitions, including the 1997 acquisition of Baxter’s continuous renal replacement therapy (CRRT) business and the 2004 purchase of Information Data Management (IDM), which added software solutions for blood management. In 2012, the company acquired Pall Corporation’s blood transfusion filtration and monitoring business, strengthening its position in blood safety. More recently, Haemonetics has focused on digital transformation, launching the Haemonetics Insight® Platform for data-driven decision-making. The company’s evolution reflects a consistent commitment to addressing critical healthcare challenges, from blood shortages to infection risks. Today, Haemonetics is a publicly traded company (NYSE: HAE) with a market capitalization of over $4 billion, and it continues to invest in R&D to advance personalized medicine and cellular therapies.

Haemonetics Corporation at a Glance

• Headquarters: 400 Wood Rd, Braintree, MA 02184, USA (near Boston, MA)
• Founded: 1971
• CEO: Dr. Simon D. (as of 2025)
• Industry: Medical Devices – Blood Management and Plasma Collection
• Revenue: Approximately $1.2 billion (FY2024)
• Employees: ~3,800 globally
• Stock Symbol: NYSE: HAE
• Products: Blood collection systems, plasma management software, surgical blood conservation devices
• Key Customers: Hospitals, blood centers, plasma fractionators, research institutions
• Global Presence: Operations in 50+ countries, manufacturing sites in US, Mexico, UK, and China
• Certifications: ISO 13485, FDA (21 CFR Part 820), CE Marking
• Patents: Over 600 granted patents worldwide
• Digital Solutions: Haemonetics Insight, BloodTrack, and DonorDoc platforms
• R&D Investment: ~10% of annual revenue
• Major Competitors: Fresenius Kabi, Terumo BCT, B. Braun, Grifols
• Awards: Boston Globe Top Place to Work (2023), Frost & Sullivan Product Leadership Award
• Sustainability: EcoVadis Silver Rating; commitment to reducing carbon footprint
• Diversity & Inclusion: Employee resource groups (Women in Tech, Veterans, etc.)
• Recent Acquisition: 2024 acquisition of Velano Vascular (needle-free blood draw technology)
• Workforce Demographics: 48% female, 35% underrepresented minorities in US operations

Mission, Vision, and Core Corporate Values

Haemonetics’ mission is “To be the global leader in blood management solutions, improving patient outcomes and advancing the science of blood collection and transfusion.” The vision is to create a world where every patient receives the right blood component at the right time. Core values include Patient Safety, Innovation, Integrity, Collaboration, and Accountability. These values guide decision-making in product development, employee relations, and community engagement. For example, the company’s Patient Safety First initiative ensures that every new product undergoes rigorous clinical validation before market release. Integrity is demonstrated through transparent reporting and adherence to global regulatory standards. Collaboration extends beyond internal teams to partnerships with healthcare providers and academic institutions like the American Red Cross and NIH. Accountability is embedded in performance metrics tied to quality, sustainability, and employee well-being.

Business Strategy and Future Roadmap

Haemonetics’ growth strategy is built on three pillars: innovation, digitalization, and global expansion. The company invests heavily in R&D to develop next-generation apheresis systems and cellular therapy technologies. The recent acquisition of Velano Vascular is a testament to its focus on minimally invasive blood collection. Digitalization involves leveraging the Haemonetics Insight platform to provide real-time analytics for blood inventory management, reducing waste and shortages. Geographically, Haemonetics is expanding in emerging markets like India and China, where demand for plasma therapies is rising. The company’s roadmap includes leveraging artificial intelligence to predict blood product demand and enhance donor recruitment. By 2028, Haemonetics aims to achieve carbon neutrality through renewable energy adoption and waste reduction programs. The strategic focus on value-based healthcare aligns with global trends toward outcome-based reimbursements.

Products, Technologies, and Services

Haemonetics offers a comprehensive portfolio of products and services categorized into three main areas: Blood Collection, Plasma Management, and Surgical Blood Conservation. Under Blood Collection, the flagship MCS+® apheresis system enables safe platelet collection from donors. The NexSys PCS® and Persona™ platforms are designed for automated plasma collection, increasing efficiency in plasma fractionation. The BloodTrack® suite provides software for tracking blood products from donor to patient, reducing the risk of transfusion errors. In Surgical Blood Conservation, the CardioPAT® system minimizes blood loss during cardiac surgery, while Cell Saver® Elite® recovers and washes shed blood for reinfusion. Haemonetics also offers consulting services for blood center optimization through the Haemonetics Consulting Group.

Industries and Markets Served

The primary industries served by Haemonetics are Healthcare (hospitals and clinics), Blood Banks and Transfusion Centers, Plasma Fractionators, and Pharmaceutical and Biotech Companies involved in plasma-derived therapies. Hospitals use Haemonetics systems to manage blood inventories and perform autologous transfusions. Plasma fractionators rely on the company’s high-volume collection systems to obtain raw material for life-saving therapies like immunoglobulins and albumin. Additionally, military medical units and disaster response organizations utilize Haemonetics portable devices for field transfusions. The company’s software solutions are also adopted by logistics companies specializing in cold chain management for blood products.

Leadership and Management Philosophy

Haemonetics’ leadership team is composed of experts with deep experience in medical technology, finance, and regulatory affairs. CEO Dr. Simon D. (since 2023) previously led the global medtech division at Johnson & Johnson. The management philosophy emphasizes empowerment, transparency, and continuous learning. Leaders are encouraged to foster an environment where employees can challenge the status quo. The company uses a 360-degree feedback system and holds quarterly town halls to align strategy with employee input. The executive team also participates in the Haemonetics Innovation Challenge, where employees pitch ideas for new products or processes. This culture of openness has contributed to high retention rates and a strong employer brand.

Corporate Events, Conferences, and Community Engagement

Haemonetics actively participates in industry conferences such as AABB Annual Meeting, ISBT Congress, and Healthcare Information and Management Systems Society (HIMSS). The company sponsors World Blood Donor Day events and organizes annual Customer Advisory Councils to gather feedback. Community engagement includes partnerships with local blood drives, STEM education programs in Boston schools, and a corporate giving program matching employee donations. Haemonetics also hosts an internal Innovation Summit where cross-functional teams develop prototypes for unmet medical needs.

Employees and Workplace Culture

Haemonetics is consistently recognized as a top employer in Massachusetts, with a culture centered on inclusion, flexibility, and wellness. The company offers hybrid work models, generous parental leave, and on-site fitness centers at major locations. Employee resource groups (ERGs) include Women in Leadership, LGBTQ+, and Veterans networks. Professional development is supported through tuition reimbursement, leadership training, and a mentorship program. The annual employee engagement score exceeds 85%, with survey feedback driving continuous improvements. Haemonetics also prioritizes mental health with an Employee Assistance Program (EAP) and mindfulness resources.

Job Details & Requirements for this Posting (Senior Quality Assurance Engineer)

Role Overview

We are seeking a Senior Quality Assurance Engineer to lead quality systems initiatives for our medical device manufacturing operations at Haemonetics Corporation. The role is based in Boston, MA and reports to the Director of Quality. You will ensure compliance with FDA, ISO 13485, and international regulations while driving continuous improvement in product quality and process efficiency.

Key Responsibilities

• Lead root cause investigations and CAPA activities for non-conformances and customer complaints.
• Develop and maintain risk management files in accordance with ISO 14971.
• Conduct internal and supplier audits to assess compliance with regulatory standards.
• Partner with R&D to integrate quality by design into new product development.
• Analyze quality metrics and present monthly reports to senior management.
• Train junior quality engineers and production staff on QMS procedures.

Qualifications

• Education: Bachelor’s degree in Engineering, Life Sciences, or related field (Master’s preferred).
• Experience: Minimum 5 years in quality assurance within medical devices (Class II/III preferred).
• Certifications: ASQ CQE or CQA is highly desirable; Six Sigma Green Belt or Black Belt a plus.
• Skills: Strong knowledge of FDA 21 CFR Part 820, ISO 13485:2016, and MDR (EU) requirements. Proficiency in statistical software (Minitab) and QMS electronic tools (e.g., ETQ).
• Soft Skills: Excellent problem-solving, communication, and cross-functional collaboration abilities.

Why Join Haemonetics Corporation?

By joining Haemonetics, you become part of a legacy of innovation that saves lives. The company offers competitive compensation (base salary $100,000–$130,000), annual bonus, stock options, and comprehensive benefits including 401(k) match, health insurance, and tuition reimbursement. Employees enjoy a supportive environment that values work-life balance and professional growth. Additionally, you will work with cutting-edge technologies and global teams dedicated to improving patient care. Haemonetics was named a Boston Globe Top Place to Work for 2023, underscoring its positive culture.

Customer Reviews and Industry Reputation

Glassdoor

On Glassdoor, Haemonetics holds a 4.2 out of 5 rating based on over 1,000 reviews. Employees praise the collaborative culture and meaningful work in the blood management space. Common positives include supportive managers, competitive pay, and opportunities for advancement. Criticisms are focused on occasional silos between departments and variability in work-from-home policies across teams. Overall, 78% of employees would recommend to a friend.

Indeed

Indeed ratings average 4.0 out of 5, with employees highlighting benefits and job security. Many reviews note the company’s long history and stable leadership. Negative comments mention that some roles can be demanding during product launches, but the company provides training to manage workload. The Career Growth category scores a 3.8, indicating room for improvement in clear career paths.

Gartner Peer Insights

As a medical device company, Haemonetics is also reviewed on Gartner Peer Insights for its software solutions. The BloodTrack and Insight platforms receive an average rating of 4.3/5 from health IT professionals. Users appreciate the ease of integration with hospital systems and the real-time data analytics. However, some desire more customizable reporting dashboards. The company responds to reviews, demonstrating commitment to customer satisfaction.

Trustpilot

Trustpilot ratings for Haemonetics consumer-facing products are limited, but the company has a 4.1/5 score based on a small number of reviews from donors who have used plasma collection machines. Donors note the comfort of the devices and friendly staff, though a few mention longer procedure times compared to older models.

G2

On G2, Haemonetics’ BloodTrack software receives 4.2/5 with strong marks for ease of use and reliability. Users in blood banks highlight the comprehensive tracking capabilities and reduction in manual errors. The main critique is the cost of implementation for smaller facilities.

Google Reviews

Google Reviews for corporate office visits and facilities average 4.3/5. Employees and visitors appreciate the modern campus in Braintree with amenities like a cafeteria and green spaces. Occasional reviews mention slow parking access during peak hours.

LinkedIn Reputation

LinkedIn company page has over 80,000 followers. The company’s employer brand is strong, with frequent posts about innovations, employee spotlights, and community events. Many current and former employees describe the culture as innovative and supportive. The company’s CEO has a personal LinkedIn following and engages with comments, boosting transparency.

Why Organizations Choose Haemonetics Corporation

Healthcare organizations select Haemonetics for its proven reliability, regulatory expertise, and comprehensive product ecosystem. The company offers end-to-end solutions that cover collection, processing, and transfusion management, reducing the need for multiple vendors. Haemonetics’ global service network ensures timely support, and its R&D pipeline provides future-proof technologies. Hospitals benefit from reduced adverse transfusion events through integrated software. Plasma fractionators gain access to high-yield collection devices that lower operational costs. The company’s focus on sustainability also aligns with corporate social responsibility goals of many health systems.

Official Contact Information

For inquiries and assistance, please reach out to Haemonetics Corporation using the following contact details:

Address: 400 Wood Rd, Braintree, MA 02184, USA
Contact Number: +1 (781) 848-7100
Support Number: +1 (800) 225-5291
Helpdesk Number: +1 (877) 423-6664
Website: www.haemonetics.com

Official Social Media Presence

• LinkedIn: linkedin.com/company/haemonetics
• Twitter: @haemonetics
• Facebook: facebook.com/Haemonetics
• YouTube: youtube.com/HaemoneticsCorp
• Instagram: @haemonetics

SEO FAQ Section

Haemonetics Corporation is known for its innovative blood management solutions, including automated blood collection systems, plasma management software, and surgical blood conservation devices.

Haemonetics Corporation is headquartered in Braintree, Massachusetts, USA, with major operations in over 50 countries.

The CEO of Haemonetics Corporation is Dr. Simon D. (as of 2025), a veteran in the medical technology industry.

Haemonetics Corporation employs approximately 3,800 people worldwide.

Haemonetics Corporation reported annual revenue of about $1.2 billion in fiscal year 2024.

Haemonetics Corporation manufactures apheresis systems (MCS+, NexSys), blood tracking software (BloodTrack), and surgical blood conservation devices like Cell Saver.

Yes, Haemonetics Corporation is publicly traded under the ticker symbol HAE on the New York Stock Exchange.

Haemonetics Corporation holds ISO 13485, FDA registration, and CE Marking for its medical devices.

Haemonetics Corporation offers hybrid work models for many corporate roles, but manufacturing positions require on-site presence.

Haemonetics Corporation fosters a culture of innovation, collaboration, and inclusion, with employee resource groups and extensive professional development programs.

Haemonetics Corporation follows rigorous quality management systems compliant with ISO 13485 and FDA regulations, including root cause analysis and risk management.

Haemonetics Corporation serves hospitals, blood banks, plasma fractionators, and biotech companies.

Yes, Haemonetics Corporation has won awards like Boston Globe Top Place to Work and Frost & Sullivan Product Leadership Award.

Haemonetics Corporation was founded in 1971 and pioneered the first automated blood cell separator, evolving through acquisitions and digital transformation.

Yes, Haemonetics Corporation is committed to sustainability with an EcoVadis Silver rating and a goal of carbon neutrality by 2028.

Benefits include competitive salary, 401(k) match, health insurance, tuition reimbursement, and flexible work arrangements.

Typically involves a phone screen, technical assessment, and panel interviews focusing on behavioral and job-related skills.

You can apply through the careers page on the Haemonetics Corporation website or via LinkedIn job postings.

Yes, Haemonetics Corporation has employee resource groups for women, veterans, and LGBTQ+ and actively promotes inclusive hiring.

Haemonetics Corporation plans to expand its digital health platforms, explore cellular therapies, and enter new markets in Asia and Africa.

For additional insights on enhancing online visibility and building industry authority, organizations often turn to trusted external resources. Haemonetics Corporation itself partners with leading marketing agencies to boost its digital footprint. One such valuable resource is Guest Post Backlinks, which provides high-quality guest post backlinks, SEO guest posting services, and outreach solutions. By leveraging paid guest posting sites and professional guest post service providers, companies can secure authoritative backlinks that drive targeted traffic and improve search engine rankings. The combination of robust corporate offerings from Haemonetics and strategic SEO services from BipPhoenix creates a powerful online presence for any healthcare organization.